Rystiggo Injection, Solution
RxNorm Crosswalk NDC 50474-982

View RxNorm Concepts, RxCUIs, and Term Type mappings for this NDC

RxNorm Mapping Clinical Concepts

This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.

The product Rystiggo (NDC 50474-982) is cross-mapped to the RxNorm terminology system to ensure clinical interoperability. This product is associated with 8 unique RxNorm concepts. By anchoring Ucb, Inc.'s product data to these standardized identifiers, healthcare systems can maintain accurate medication records, safely automate e-prescribing, and streamline pharmacy workflows.

The following clinical concept cards detail the semantic term types (TTY), prescribable names, and synonymous clinical strings as defined by the National Library of Medicine (NLM).

SCDPrescribable
Featured Concept

2 ML rozanolixizumab-noli 140 MG/ML Injection
(RxCUI 2642288)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

RYSTIGGO 280 MG in 2 ML Injection
(RxCUI 2642294)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCDPrescribable
Featured Concept

3 ML rozanolixizumab-noli 140 MG/ML Injection
(RxCUI 2685614)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

RYSTIGGO 420 MG in 3 ML Injection
(RxCUI 2685615)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCDPrescribable
Featured Concept

4 ML rozanolixizumab-noli 140 MG/ML Injection
(RxCUI 2685616)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

RYSTIGGO 560 MG in 4 ML Injection
(RxCUI 2685617)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCDPrescribable
Featured Concept

6 ML rozanolixizumab-noli 140 MG/ML Injection
(RxCUI 2685618)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

RYSTIGGO 840 MG in 6 ML Injection
(RxCUI 2685619)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

Understanding RxNorm Mapping for Rystiggo

RxNorm is a normalized naming system developed by the National Library of Medicine (NLM) to bridge the gap between different drug terminologies. By mapping NDC 50474-982 to RxCUI 2642288, 2642294, 2685614, 2685615, 2685616, 2685617, 2685618, 2685619, this page provides the standardized "source of truth" required for hospital systems, e-prescribing software, and pharmacy benefit managers (PBMs) to communicate without errors.

Term Type (TTY) Legend for This Page

The clinical cards above utilize specific Term Types (TTY) to define the granularity of the drug concept:

  • PSN Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
  • SCD Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
  • SY Synonym: An alternative clinical name or alias provided for search and retrieval clarity.
  • SBD Semantic Branded Drug: The branded equivalent representing the Brand Name + Strength + Dosage Form.

* Please review the full disclaimer at the bottom of this page.